Efficacy of thymosin α1 in patients with chronic hepatitis B: A randomized, controlled trial
Rong‐Nan Chien, Yun‐Fan Liaw, Tse‐Ching Chen, Chau‐Ting Yeh, I.‐Shyan Sheen – 30 December 2003 – Thymosin α1 (Tα) is an immune modifier that has been shown in a pilot study to be effective for chronic hepatitis B; this requires confirmation.